chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt devel chills, perioral cyanosis, & fever to 103.6 approx 60 min post vax; Observed in clinic, 02 per face mask, Advil;
The evening she received her vaccine, the patient experience arm swelling and red spots around the injection site. The following morning she developed vertigo. Her symptoms resolved within 7 days. The patient did experience the same side effects with doses #1 and #2,  patient reports symptoms lasted about 8 weeks at that time.
pain in arm; No appetite for a couple of days.; Swelling from my elbow to my shoulder; Entire site is hot; Angry red patch an inch below the injection site; chills; vaccination site swelling; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (pain in arm), DECREASED APPETITE (No appetite for a couple of days.), SWELLING (Swelling from my elbow to my shoulder), VACCINATION SITE WARMTH (Entire site is hot) and VACCINATION SITE ERYTHEMA (Angry red patch an inch below the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041l20a and 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included B12 deficiency anemia and Angioplasty (HEART ANGIOPLASTY) on 19-Mar-2019. Previously administered products included for an unreported indication: B12 1000 SR on 02-Dec-2020. Concurrent medical conditions included Tetanus, Milk allergy, Allergy NOS (OFF INSECT SPRAY) and Blood pressure high since 15-Mar-2019. Concomitant products included LOSARTAN from 19-Mar-2019 to an unknown date and METOPROLOL from 19-Mar-2019 to an unknown date for Blood pressure high, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) from 19-Mar-2021 to an unknown date for Heart disorder, PARACETAMOL (TYLENOL) and FLUTICASONE for an unknown indication.   On 30-Dec-2020 at 2:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (pain in arm), DECREASED APPETITE (No appetite for a couple of days.), SWELLING (Swelling from my elbow to my shoulder), VACCINATION SITE WARMTH (Entire site is hot), VACCINATION SITE ERYTHEMA (Angry red patch an inch below the injection site), CHILLS (chills) and VACCINATION SITE SWELLING (vaccination site swelling). On 02-Feb-2021, SWELLING (Swelling from my elbow to my shoulder) and VACCINATION SITE WARMTH (Entire site is hot) had resolved. On 10-Feb-2021, PAIN IN EXTREMITY (pain in arm), DECREASED APPETITE (No appetite for a couple of days.), VACCINATION SITE ERYTHEMA (Angry red patch an inch below the injection site), CHILLS (chills) and VACCINATION SITE SWELLING (vaccination site swelling) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, Body temperature: 101.4 f High.         Treatment medications included Tylenol   This case was linked to MOD21-15908, MOD-2021-025534 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2021: Follow up received on 07-APR-2021 and added Med History updated and outcome of events updated
I received 1st Covid shot on Feb 18, 2021. On March 4,2021, I was taken to Med Center by ambulance after having a small stroke that am. I don't know if there is any correlation? Did not think so, as I received my second Covid shot on March 18th, without any adverse reaction at all. I am only sending this o you as I wws informed that you would want to know about this?
NURSE GAVE VACCINE OUTSIDE IN PATIENT VAN WITH MOM AND BROTHER PRESENT. PT TOLERATED VACCINE WELL. PT WAITED ON SITE FOR 15 MIN. AFTER VACCINE WITHOUT ISSUES. MOM STATES DAYS FOLLOWING VACCINE PT MAY HAVE HAD SOME FACIAL TWITCHING AND SHALLOW BREATHING. UNSURE BECAUSE SHALLOW BREATHING WAS NORMAL FOR PATIENT.  GAVE MOM NUMBER TO REPORT INCIDENT.
Case number PHEH2015US021584, is an initial spontaneous report received from healthcare professional on 21 Oct 2015. This report refers to a 29 year old female patient. Historical condition and concomitant medication were not provided. The patient was vaccinated with FLUVIRIN (batch number: 1516401) intramuscularly on 15 Oct 2015. It was reported that during vaccination vial leakage was observed from the point where diaphragm and metal meet. Further there was no harm caused to patient and no medical attention was required. No adverse event was reported following this event.
numbness on injection site; knot on her left shoulder blade; itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ANAESTHESIA (numbness on injection site), MASS (knot on her left shoulder blade) and VACCINATION SITE PRURITUS (itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ANAESTHESIA (numbness on injection site), MASS (knot on her left shoulder blade) and VACCINATION SITE PRURITUS (itchy). At the time of the report, VACCINATION SITE ANAESTHESIA (numbness on injection site), MASS (knot on her left shoulder blade) and VACCINATION SITE PRURITUS (itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information or concomitant medications were provided.
Wheezing, coughing, choking, flushed, lethargic. Treated with Andrenaline, Benadryl, IV fluids, oxygen at 2L /min, Solu-Medrol. Hospital admission for observation.
Was administered DTaP and MMR on left lateral leg resulting in redness to area with intermittent itching.  Bruise in area developed a few days later.  Currently, (i month later) continues with dark circle 2-6 cm in diameter.  Denies pain or discomfort.
No adverse event; receiving two doses at the same day instead of one; Accidental overdose/administration error; This spontaneous case was reported by a pharmacist and describes the occurrence of EXTRA DOSE ADMINISTERED (receiving two doses at the same day instead of one), ACCIDENTAL OVERDOSE (Accidental overdose/administration error) and NO ADVERSE EVENT (No adverse event) in an 81-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 2 dosage form. On 22-Sep-2022, the patient experienced EXTRA DOSE ADMINISTERED (receiving two doses at the same day instead of one) and ACCIDENTAL OVERDOSE (Accidental overdose/administration error). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXTRA DOSE ADMINISTERED (receiving two doses at the same day instead of one), ACCIDENTAL OVERDOSE (Accidental overdose/administration error) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXTRA DOSE ADMINISTERED (receiving two doses at the same day instead of one) and ACCIDENTAL OVERDOSE (Accidental overdose/administration error).    No concomitant medication was reported. A patient was administered 2 doses of the bivalent booster Moderna COVID19 vaccine because of an administration error on the same day. No treatment medication was reported.
patient states some soreness after vaccine. Starting 9/26/21 she experienced pain and difficulty moving arm above shoulder-line.
LOSS OF FINE MOTOR CONTROL IN RIGHT ARM; HEADACHE; This spontaneous report received from a patient concerned a 76 year old female. The patient's weight was 130 pounds, and height was 65 inches. The patient's past medical history included pacemaker for nerve block (4-5 years ago), appendectomy (10 years ago), cataract surgery, and concurrent conditions included alcohol user (occasional, not often), and ex-smoker (used to smoke for 30 years (half pack a day), but quit 10 years ago) and bladder cancer growth (7 years ago). The patient experienced drug allergy with opioids (deathly ill, sick to stomach and passes out). The patient was not pregnant at the time of reporting.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: 25-MAY-2021) dose was not reported, 1 total, administered on right arm on 09-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 17-MAR-2021, the patient experienced headache. On 21-MAR-2021, the patient lost fine motor control in right arm, and was hospitalized for 2 days. It was reported that, the patient had 2 computerized tomography scans showed no evidence of clot however according to the patient's physician, the patient might have had small clot that dissolved. The patient had no high blood pressure. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from loss of fine motor control in right arm on 21-MAR-2021, and headache on 2021. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0 This report concerns a 76-year-old female patient who experienced headache and loss fine motor control in right arm, 8 and 12 days after receiving Jansen COVID-19 vaccine respectively. Patient's medical history included pacemaker insertion, ex-smoker, bladder cancer, and drug allergy with opioids. Eight days after vaccination, the patient had headache. Four days later, the patient lost fine motor control in right arm and was hospitalized for one and a half days. Two CT scans showed no evidence of clot. The patient's physician commented that the patient might have had small clot that dissolved. The treatment was not reported, and patient was recovered from the events.  Based on the reported information, the causality is considered possible to vaccine for headache and unassessable for the event of loss fine motor control in right arm.
1 1/2 hours after receiving intramuscular injection had "lump in throat, watery swollen reddened eyes without pain, fever to max 100.2 and chills and feeling "bad" with eventual tachycardia to 132 bpm.
Pfizer-BioNTech COVID-19 Vaccine EUA.  I had soreness and pain through my whole arm within 6 hours of injection. It spread to my back and the back of my head, with chills.  THE NEXT DAY, it felt like my lungs were in 'overdrive' trying to get a full breath of air. Every time I exhaled, it felt like something was squeezing my lungs tighter and was difficult to breath normal. I felt dizzy, weak, and thought I may at some point pass out.  I suffer from rapid heart palpitations, and I experienced this during my event as well.
Sunday morning when I woke up, I noticed a dull discomfort in my left side. It felt like I pulled a muscle or something. I was sitting on the deck and the discomfort turned into pain. The pain radiated up and down my side then went into my left upper thigh. It was an on and off pain that kept getting worse. My mom was with me and she said I turned sheet white. I saw everything turn bright and I was told that I passed out. I was probably out for a minute. When I came through, I was covered in sweat and the pain and the discomfort continued for another 10 minutes until it passed. I didn't go to the hospital. My blood pressure was low 102/60, but not too low. I didn't do much the rest of the day, I just rested. Monday, I called and left a message for my doctor. I wasn't able to get a hold of them until Tuesday and I saw my doctor that day. She made a referral to see a neurologist. Unsure if this is in relation at this time.
Body aches. Flu like symptoms .Dizzy  and lots of pain. Feeling Cold . Body shaking.
Localized vaccine reaction with warmth, edema left upper arm less than 24 hours with concurrent MMR, IPV, DTAP.  Arm swollen shoulder-elbow.  No systemic urticaria or respiratory distress.
Approximately 48 hours after receiving Pfizer Covid-19 mRNA vaccine, patient starting immediately throwing up with diarrhea and then developed chest pain and breaking out into hives, then her face started swelling on R side, phlegm in her throat, rashes on her feet; had full blown panic attack once she saw the face swelling; was too nervous to use her epinephrine pens.  Took Xanax, Zyrtec and Benadryl.
Fever, tiredness, headaches, sore throat, muscle pain, and inability to move the left arm.
Patient called and states she received the Flu injection at the Pharmacy and was having a localized reaction.
Systemic: Other- cardiopulmonary arrest 5 hours after vaccine-Severe
3pm child developed hives on chest and face eyelids swollen. Telephone call from patient and instructed to call 911. Taken to ER, given IV fluids and Benadryl. 5pm child comfortable, will be discharged.
FAINTING, PALENESS, THROAT CLOSING, LOSS OF HEARING IN 1 EAR, IMMEDIATE HEADACHE, 103 DEGREE TEMP ABOUT 1.5 HOURS LATER WITH STIFF NECK AND WEAK PAINFUL LEGS AND ACHES AND PAINS.
Atrial fibrillation; This is a spontaneous report from a contactable consumer (patient himself). A 46-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot/batch number not provided), via an unspecified route of administration at Left arm on 23Feb2021 12:00 pm (at 46-year-old) at single dose for COVID-19 immunisation in hospital. Medical history included Seminoma from 2011, Suframides allergy. The patient's concomitant medications were not reported. The patient experienced Atrial fibrillation on 25Feb2021 02:30 am. No other vaccine in four weeks. No Other medications in two weeks. No COVID prior vaccination. No COVID tested post vaccination. The events were not resulted in emergency room visit or physician office visit. No treatment received. The outcome of the event was Recovered on 25Feb2021.   Information on the lot/batch number has been requested.
Did not have any symptoms after the vaccination, but months after the vaccination had COVID and had all COVID symptoms, fatigue, tired, headaches, chills, no appetite.
Bleeding gums; This is an spontaneous report from a contactable consumer based on information received by Pfizer from license party for apixaban (ELIQUIS).  This case was received via Pfizer Inc (Reference number: 2021089295) on 28-Jan-2021 and was forwarded to Company on 29-Jan-2021. This spontaneous case was reported by a patient family member or friend and describes the occurrence of gingival bleeding (Bleeding gums) in 82-year-old male patient who received Apixaban (ELIQUIS) for Cerebrovascular accident prophylaxis. Co-Suspect Products included clopidogrel bisulfate (Plavix) for an unknown indication and Covid-19 Vaccine for COVID-19 prophylaxis. Concurrent medical conditions included Diabetes (Diagnosed 40 years ago, type 2), Blood pressure high and Cardiac disorder NOS. In July 2020, the patient started ELIQUIS (unknown route), 5 milligram twice a day. On an unknown date, the patient started Plavix (unknown route) 75 milligram at an unspecified frequency. On 28-Jan-2021, the patient started Covid-19 Vaccine (unknown route). On the same day, the patient experienced gingival bleeding (Bleeding gums). The dose of ELIQUIS(Unknown) and Plavix (Unknown) was not changed. At the time of the report, gingival bleeding was resolving. For ELIQUIS(Unknown), the reporter did not provide any causality assessments. For Plavix(Unknown), the reporter did not provide any causality assessments.
I had my vaccination on 11/01/2022. I started to have flu like symptoms on 01/03/2023. I tested COVID-19 Positive on 01/05/2023. I contacted my physician who prescribed Paxlovid. It took at least 10 days or more to test negative. I presently feel fine on 05/15/2023.
Patient stated 30 minutes after vaccine (Hep B), nauseated, dizziness, sometime after 2:00 PM. Seen in ER @ 11:00 PM, c/o N & V, chills, dizziness. Next day feeling better but just weak.
Very sore muscles especially in the injection arm. Lack of appetite. Very tired. Nausea began on evening of April 6th and persisted until medication was taken (ondansetron) to stop it.
had all the symptoms; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT FOLLOWING IMMUNISATION (had all the symptoms) and FATIGUE (fatigue) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT FOLLOWING IMMUNISATION (had all the symptoms) and FATIGUE (fatigue). At the time of the report, ADVERSE EVENT FOLLOWING IMMUNISATION (had all the symptoms) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment information was not reported.
Child had MMR and Flu vaccine 11-1-13 she developed a fever and had a seizure with coma - adm PICU 11-8-13.
PATIENT REQUESTED 'BOOSTER' AND PRESENTED A VACCINE CARD WITH TWO VACCINE DOSES (3/18/21 AND 4/15/21)  I ADMINISTERED WHAT I BELIEVED TO BE HER 3RD  SHOT OR BOOSTER AS IT WOULD BE 5 MONTHS FROM THE SECOND AND APPROPRIATE. SHE ASKED WHAT TO EXPECT FROM THE BOOSTER AND WE DISCUSSED.  AFTER WHILE REPORTING TO THE STATE RECORD-KEEPING SITE, IT WAS DISCOVERED SHE HAD ALREADY GOTTEN A BOOSTER AT ANOTHER PHARMACY AT 8/29/21 WHICH SHE HAD CONCEALED FROM US.  THE ONE THAT I GAVE WAS ACTUALLY A 4TH WHICH SHE DID NOT QUALIFY FOR.
Body aches, chills, fever, fatigue.  Treatment  include Tylenol and Motrin. Fever resolved
No adverse effects; The patient received the first dose of GARDASIL 9 on 01-AUG-2018 and the second dose of GARDASIL 9 on 07-AUG-2019; This spontaneous report has been received from a nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant mediations and drug reactions or allergies were not provided.  On 01-AUG-2018, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) 0.5 ml (route, lot number: N028567 and expiration date: 17-MAY-2020) for prophylaxis. On 07-AUG-2019, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) 0.5 ml (route, lot number: R008165 and expiration date: 12-NOV-2020) for prophylaxis. The second dose was a late dose (inappropriate schedule of vaccine administered). No adverse effects reported. No further information was provided.
no adverse event; Nurse reporting AE for improperly stored PROQUAD administered; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 04-AUG-2022, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) (lot #W002783 and expiration date: 24-JUL-2023; strength, dosage regimen, anatomical location, and route of administration were not provided) that had underwent a temperature excursion of -14.2 degree for 40 minutes with previous temperature excursion of -14.5 celsius degrees during 10 minutes (product storage error). The vaccine was administered as prophylaxis. No adverse event was reported.  This is one of the several cases reported from the same reporter.; Sender's Comments:  US-009507513-2208USA004029:Case # 02220597
This spontaneous report as received from a healthcare worker refers to unknown number of patients of unknown age. The unknown number of patients had received ZOSTAVAX (lot number not provided) and VARIVAX (Merck) (lot number not provided) doses which were exposed to -6.8C for 1.5 hours every 24 hours due to defrost cycle every day. No adverse effect reported. It was unspecified if the patients had sought medical attention. The health care professional contacted during telephone follow-up did not remember which patient might have received these vaccines and could not supply the following information: patient name, date of birth, dates of vaccination, or lot number. She also stated that the vaccines have been moved to a proper storage unit. Follow-up information received from the healthcare worker. Patient information was updated. On 30-SEP-2013 the patient was vaccinated with a dose of improperly stored ZOSTAVAX (lot#, expiration date and route not reported). This is one of the several reports from the same source. Additional information has been requested.
Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, FLANK PAIN Narrative: Employee had the second dose covid vaccine 01/28/21, 330pm. He stated that he had worsening malaise, body ache fever, flank pain with intermittent nausea the following day 1/28/21 He related to muscle pain at both thighs and flu like symptoms He stated that he took tylenol/muscular relaxant/neuontin with minimal relief. He did not seek medical attention
7 booster doses of the Moderna Covid-19 Vaccine given on 3Jan2022 were past the 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (7 booster doses of the Moderna Covid-19 Vaccine given on 3Jan2022 were past the 30-day Use By Date) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (7 booster doses of the Moderna Covid-19 Vaccine given on 3Jan2022 were past the 30-day Use By Date). On 03-Jan-2022, EXPIRED PRODUCT ADMINISTERED (7 booster doses of the Moderna Covid-19 Vaccine given on 3Jan2022 were past the 30-day Use By Date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication was reported.  The vial was initially stored in the refrigerator on 1 Dec 2021 and the vaccine was administered on 03 JAN 2022(booster dose). The vial did not undergo any temperature excursions.
Information has been received from a certified medical assistant concerning a 13 month old male with no pertinent medical history and no drug reactions/allergies who on approx 17Sep05 was vaccinated with a 0.5mL dose of varicella virus vaccine live (lot651045/0324R). There was no concomitant medication. On approx 07Oct05 the pt developed 40 lesions located on various parts of his body. The outcome was reported as not recovered. There were no lab diagnostic studies performed. Unspecified medical attention was sought. No further information was available at the time of the report. There was no product quality complaint. Additional information has been requested.
Information has been received from a 22 year old female, who, on an unspecified date, was vaccinated with a second dose of Gardasil.  Subsequently, the patient experienced a panic attack.  The patient went to the emergency room but was not admitted.  At the time of the report she was still experiencing the panic attacks.  No product quality complaint was involved.  Additional information is not expected.